Trial Information
Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery
Inclusion Criteria
Inclusion Criteria
- Age: 18-75
- Basal cell carcinoma or squamous cell carcinoma of the head or neck
- Subjects are in good health
- Subjects that have the willingness and the ability to understand and provide informed
consent for the use of their blood and communicate with the investigator
Exclusion Criteria
- Lidocaine sensitivity
- Bleeding disorder
- Pregnancy
- Medical conditions which would impair hepatic blood flow: congestive heart failure,
liver dysfunction, peripheral vascular disease.
- Subjects who are unable to understand the protocol or to give informed consent
- Subjects with mental illness
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
The Number of Subjects With Detectable Serum Lidocaine Concentrations (<0.1 ug/mL) at Each Blood Draw.
Outcome Time Frame:
6 hours
Safety Issue:
No
Principal Investigator
Murad Alam, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Northwestern University
Authority:
United States: Institutional Review Board
Study ID:
MA-stu1404
NCT ID:
NCT00793169
Start Date:
September 2007
Completion Date:
July 2008
Related Keywords:
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- squamous cell carcinoma of the head or neck
- Carcinoma
- Carcinoma, Basal Cell
- Carcinoma, Squamous Cell
Name | Location |
Northwestern University |
Chicago, Illinois 60611 |